Triglyceride response to intravenous lipid emulsion in small vs non-small for gestational age newborns: a retrospective cohort
Journal of Pediatric and Neonatal Individualized Medicine · 2026-04 · 15 (1) · e150116-e150116
DOI: 10.7363/150116 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pediatric and Neonatal Individualized Medicine, 2026-04. Verfasst von Sagee Nissimov und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Small for gestational age (SGA) infants may have reduced lipid tolerance during intravenous lipid emulsion (ILE) therapy. We compared triglyceride (TG) levels in SGA versus non-SGA neonates receiving ILE and explored associations with neonatal morbidities.
Methods
This retrospective study included neonates who received ILE for at least 24 hours. TG levels were measured at approximately 24 hours of life and at 30-60 days. Statistical analyses compared TG levels, the incidence of hypertriglyceridemia (TG > 250 mg/dL), and the change in TG levels over time between the groups.
Results
165 neonates were included, 56 (33.9%) SGA and 109 (66.1%) non-SGA. The mean ± SD gestational age at birth and birth weight were 34.2 ± 3.0 vs. 29.8 ± 2.6 weeks (p < 0.001), and 1,446 ± 336 vs. 1,325 ± 350 grams, respectively (p = 0.02). TG levels at 24 hours were significantly higher in the SGA group (144 [98, 189] vs. 85 [62, 116] mg/dL, p < 0.001). Incidence of hypertriglyceridemia was higher in SGA infants (10.7% vs. 1.8%, p = 0.019). Despite shorter duration of exposure (3.0 [2.0, 4.5] vs. 4.5 [3.0, 7.0] days, p < 0.001), a subgroup of SGA infants with follow-up data had higher TG levels at 30-60 days of life compared to non-SGA infants (106 [84, 155] vs. 70 [56, 91] mg/dL, p = 0.005). In multivariable analysis, SGA status, intraventricular hemorrhage, use of cardiotropic agents, and ClinOleic (vs. SMOFlipid) were independently associated with higher TG at 24 hours.
Conclusion
SGA infants showed higher early TG levels and greater risk of hypertriglyceridemia during ILE, with elevations persisting at 30-60 days in the subgroup of SGA infants with follow-up data available. These findings support early TG monitoring and individualized lipid titration for SGA infants. Interpretation should consider the retrospective single-center design, baseline differences between SGA and non-SGA infants, and limited SGA follow-up sampling.
Schlagwörter
Zitieren
APA
Nissimov, S., Hofi, L., Cahanovitc, S. S., Simpson-Lavy, Y., Shaniv, D., & Hershkovich-Shporen, C. (2026). Triglyceride response to intravenous lipid emulsion in small vs non-small for gestational age newborns: a retrospective cohort. Journal of Pediatric and Neonatal Individualized Medicine, 15(1), e150116-e150116. https://doi.org/10.7363/150116
Vancouver
Nissimov S, Hofi L, Cahanovitc SS, Simpson-Lavy Y, Shaniv D, Hershkovich-Shporen C. Triglyceride response to intravenous lipid emulsion in small vs non-small for gestational age newborns: a retrospective cohort. Journal of Pediatric and Neonatal Individualized Medicine. 2026;15(1):e150116-e150116. doi:10.7363/150116
BibTeX
@article{Nissimov2026,
author = {Nissimov, Sagee and Hofi, Lilach and Cahanovitc, Sharon Sarah and Simpson-Lavy, Yael and Shaniv, Dotan and Hershkovich-Shporen, Calanit},
title = {Triglyceride response to intravenous lipid emulsion in small vs non-small for gestational age newborns: a retrospective cohort},
journal = {Journal of Pediatric and Neonatal Individualized Medicine},
year = {2026},
volume = {15},
number = {1},
pages = {e150116--e150116},
doi = {10.7363/150116}
}
EUVIMED